Social networks
784Activities
Technologies
Entity types
Location
Centro de I+D en Electrónica y Comunicaciones, C. Tajonar, 22, 31006 Pamplona, Navarra, Spain
Pamplona
Spain
Employees
Scale: 2-10
Estimated: 10
Engaged corporates
7Added in Motherbase
9 months agoWhat you breath reveals
We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test.
I+D, Biomarcadores exhalados, Óxido Nítrico, Fabricación, Comercialización, ISO13485, Dispositivos Médicos, Patentes, eHealth, R&D, Exhaled Biomarkers, Nitric Oxide, Manufacturing, Commercialization, Medical Devices, Patents, FeNO, and Asthma diagnostic and management
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Other 16 Apr 2024 | | |
Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Apr 2024 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 20 May 2024 | | |
GSK Pharmaceutical, Pharmaceutical Manufacturing | GSK Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Apr 2024 | | |
Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Apr 2024 | | |
CaixaBank Bank, Banking | CaixaBank Bank, Banking | Other 29 Feb 2024 | | |
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 16 Apr 2024 | |